Literature DB >> 10491026

Amphicrine tumor.

L Mándoky1.   

Abstract

The term amphicrine refers to cells, and tumors, which show both exocrine and endocrine features. Author s aim was to analyse the characteristics of these neoplasms. 40 suspicious cases were reviewed. Mucin-stains (PAS, diastase-PAS, Stains-all, Alcian-blue), immunohistochemistry (antibodies against Neuron-Specific Enolase (NSE), and Chromogranin A (CGA), and electronmicroscopic studies were performed to demonstrate exocrine and/or endocrine features of the tumor cells. By means of these methods, 16 cases turned out to be amphicrine tumors. Among them, there were 4 sinonasal, 1 bronchial, 1 mediastinal, 8 gastrointestinal and 2 suprarenal gland neoplasms. In connection to the subject, a brief review is given of amphicrine tumor, regarding its etiological and pathological aspects. These tumors form a distinct clinicopathological entity and should be separated from both neuroendocrine tumors and adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491026     DOI: 10.1053/paor.1999.0211

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  43 in total

1.  Immunohistochemical characterization of an amphicrine mucinous islet-cell carcinoma of the pancreas. Case report.

Authors:  V J Laine; T O Ekfors; R Gullichsen; T J Nevalainen
Journal:  APMIS       Date:  1992-04       Impact factor: 3.205

2.  Ultrastructural study of a mucinous carcinoid of the skin.

Authors:  F Sakamoto; M Ito; G Matumura; Y Sato; S Kimura
Journal:  J Cutan Pathol       Date:  1991-04       Impact factor: 1.587

3.  Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras. The problem of the neurectodermal origin of the cells of the APUD series.

Authors:  J Fontaine; N M Le Douarin
Journal:  J Embryol Exp Morphol       Date:  1977-10

Review 4.  Histopathological classification of nonantral gastric endocrine growths in man.

Authors:  E Solcia; C Bordi; W Creutzfeldt; Y Dayal; A D Dayan; S Falkmer; L Grimelius; N Havu
Journal:  Digestion       Date:  1988       Impact factor: 3.216

5.  Intestinal metaplasia with argentaffin cells in cervical adenocarcinoma.

Authors:  J G Azzopardi; L T Hou
Journal:  J Pathol Bacteriol       Date:  1965-10

6.  Ultrastructural features of neuroendocrine differentiated carcinomas of the breast.

Authors:  C Capella; L Usellini; M Papotti; L Macrì; G Finzi; V Eusebi; G Bussolati
Journal:  Ultrastruct Pathol       Date:  1990 Jul-Aug       Impact factor: 1.094

7.  The amphicrine (endo-exocrine) cells in the human gut, with a short reference to amphicrine neoplasias.

Authors:  M Ratzenhofer; L Auböck
Journal:  Acta Morphol Acad Sci Hung       Date:  1980

8.  The endodermal origin of the endocrine cells of an adenocarcinoma of the colon of the rat.

Authors:  W F Cox; G B Pierce
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

9.  Multiple carcinoids and endocrine cell micronests in type A gastritis. Their morphology, histogenesis, and natural history.

Authors:  M Itsuno; H Watanabe; M Iwafuchi; S Ito; N Yanaihara; K Sato; M Kikuchi; N Akiyama
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

10.  Endocrine differentiation in basal cell carcinoma.

Authors:  V Eusebi; V Mambelli; V Tison; R De Lellis; C M Betts
Journal:  Tumori       Date:  1979-04-30
View more
  2 in total

Review 1.  Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Authors:  Guido Rindi; Ozgur Mete; Silvia Uccella; Olca Basturk; Stefano La Rosa; Lodewijk A A Brosens; Shereen Ezzat; Wouter W de Herder; David S Klimstra; Mauro Papotti; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2022-03-16       Impact factor: 3.943

2.  Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity.

Authors:  Dan Huang; Fei Ren; Shujuan Ni; Cong Tan; Weiwei Weng; Meng Zhang; Midie Xu; Lei Wang; Qinghua Xu; Weiqi Sheng
Journal:  Cancer Cell Int       Date:  2019-11-21       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.